Medicare proposes limiting coverage of controversial Alzheimer's drug

Jan 13, 2022
Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.
A sign for biotechnology company, Biogen, Inc. is seen on a building in Cambridge, Massachusetts.
DOMINICK REUTER/AFP via Getty Images

Federal pharma ingredient stockpile is under construction in Virginia

Oct 19, 2021
The stockpile is a way to address shortages of some medicines. Some of the ingredients will be stored for emergency use.
Construction is underway in Petersburg, Virginia, on buildings to house a stockpile of pharmaceutical ingredients.
Nancy Marshall-Genzer

The antibiotics industry is in trouble. Operation Warp Speed may hold some solutions.

Jul 7, 2021
The antibiotics sector needs a revitalizing shot. The U.S. government's response to COVID may hold some answers.
Joe Raedle/Getty Images

Caution: Kodak's comeback may not be picture-perfect

Aug 7, 2020
The Trump administration has given Kodak hundreds of millions of dollars to produce chemicals for COVID-19 treatments. But the venerable photography company will have to compete with a global supply chain.
Kodak once could claim the majority of the global film market. Now, it's being tapped to produce chemicals for potential COVID-19 treatments.
Chris Furlong/Getty Images

U.S. and EU vaccine deals raise fears of 'vaccine nationalism'

Jul 31, 2020
What does it mean for the rest of the world if countries have dibs on vaccine doses?
President Donald Trump tours a North Carolina lab making components for a potential vaccine. The U.S. has struck deals with drug companies for access to coronavirus vaccines in development.
Jim Watson/AFP via Getty Images

Prescription drug supply could be hit by COVID-19

Feb 26, 2020
China plays a big part in the supply chain of Americans' generic drugs
COVID-19 could affect the supply of prescription drugs worldwide.
Dale de la Rey/AFP via Getty Images

The future is bright … let’s make it even brighter together.

Be a Marketplace Investor with a donation in any amount today.

New gene therapy drug expected to hit market with head-spinning price tag

May 22, 2019
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Swiss pharmaceutical giant Novartis' Basel headquarters.
SEBASTIEN BOZON/AFP/Getty Images

Would requiring prices in pharmaceutical ads make drugs cheaper?

Apr 9, 2019
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Philippe Huguen/AFP/Getty Images

Walgreens has a tough quarter

Apr 2, 2019
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear the full story.
People walk by a Walgreens store in San Francisco.
Justin Sullivan/Getty Images